E713-0273 Screening compound: 1-benzyl-4-[3-(3,4-dimethoxyphenyl)-1,2,4-oxadiazol-5-yl]piperazine

E713-0273 Screening compound: 1-benzyl-4-[3-(3,4-dimethoxyphenyl)-1,2,4-oxadiazol-5-yl]piperazine
E713-0273 Screening compound: 1-benzyl-4-[3-(3,4-dimethoxyphenyl)-1,2,4-oxadiazol-5-yl]piperazine alternative view

Chemical Structure Depiction of ChemDiv screening compound E713-0273
1-benzyl-4-[3-(3,4-dimethoxyphenyl)-1,2,4-oxadiazol-5-yl]piperazine

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

E713-0273

Molecular Formula

C21H24N4O3 (C21 H24 N4 O3)

Compound Name

1-benzyl-4-[3-(3,4-dimethoxyphenyl)-1,2,4-oxadiazol-5-yl]piperazine

IUPAC name

1-benzyl-4-[3-(34-dimethoxyphenyl)-124-oxadiazol-5-yl]piperazine

SMILES

COc(ccc(-c1noc(N2CCN(Cc3ccccc3)CC2)n1)c1)c1OC

InChI

InChI=1S/C21H24N4O3/c1-26-18-9-8-17(14-19(18)27-2)20-22-21(28-23-20)25-12-10-24(11-13-25)15-16-6-4-3-5-7-16/h3-9,14H,10-13,15H2,1-2H3

InChI Key

MJYOWVYXFMOTID-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD14911301

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

380.45

Hydrogen Bond Acceptors Count

6.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

6.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

3.429

Distribution Coefficient, logD

3.266

Water Solubility, LogSw

-3.58

Polar Surface Area

54.241

Acid Dissociation Constant (pKa)

23.25

Base Dissociation Constant (pKb)

7.06

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

33.30

E713-0273 in Drug Discovery

Included in Screening Libraries

Antimitotic Tubulin Library (17355 compounds)

GPCR Targeted Library (31838 compounds)

Ion Channels Focused Library (26372 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
  • Musculoskeletal
  • Respiratory tract
  • Nervous system
  • Congenital
  • Skin
  • Metabolic
  • Endocrine
  • Nervous system
  • Cardiovascular
Targets:
  • GPCR
  • Ion Channels
Mechanism of action:
  • Receptor's ligands

References: we are preparing a list of scientific research reports with E713-0273 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound E713-0273?
Check Price and Availability of E713-0273, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of E713-0273 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for E713-0273
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for E713-0273
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of E713-0273 available by request